Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Clinical trial NCT00334139 · COMPLETED

Trial details

NCT number: NCT00334139
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer Breast Cancer Bone Metastasis

Start date: 2006-05-01
Primary completion: 2009-07-01
Enrollment: 411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.